General MedicationsORALStandard
FENOFIBRIC ACID
CHOLINE FENOFIBRATE
Standard Dose
EQ 135MG FENOFIBRIC ACID
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FENOFIBRIC ACID is listed in Drugs@FDA under application 213450 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CHOLINE FENOFIBRATE Form and strength CAPSULE, DELAYED RELEASE;ORAL - EQ 135MG FENOFIBRIC ACID Sponsor MICRO LABS Submission history Latest submission status date: 2023-07-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview FENOFIBRIC ACID is listed in Drugs@FDA under application 213450 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CHOLINE FENOFIBRATE Form and strength CAPSULE, DELAYED RELEASE;ORAL - EQ 135MG FENOFIBRIC ACID Sponsor MICRO LABS Submission history Latest submission status date: 2023-07-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.